"10.1371_journal.pone.0037442","plos one","2012-05-29T00:00:00Z","José R Santos; José Moltó; Josep M Llibre; Eugenia Negredo; Isabel Bravo; Arelly Ornelas; Bonaventura Clotet; Roger Paredes","Lluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Econometrics, Statistics and Spanish Economy, University of Barcelona, Barcelona, Spain; IrsiCaixa Foundation, Barcelona, Spain","Contributed to the study design: JRS JM JML EN RP BC. Analyzed the data: AO. Contributed reagents/materials/analysis tools: IB. Wrote the paper: JRS JM JML RP EN.","José R Santos has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Bristol-Myers Squibb, ViiV Healthcare, and Pfizer. José Moltó has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Bristol-Myers Squibb, ViiV Healthcare, and Pfizer. Josep M Llibre has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Merck Sharp & Dohme, Pfizer, and Roche. Eugenia Negredo has received research honoraria for speaking and serving on advisory boards from Abbott, Bristol-Myers Squibb, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Roche, Janssen-Cilag, and Merck Sharp & Dohme. Bonaventura Clotet has received research funding, consultancy fees, and lecture fees from and has served on advisory boards for Abbott, Boehringer-Ingelheim, Gilead Sciences, Glaxo Smith-Kline, Janssen-Cilag, Merck Sharp & Dohme, Panacos, Pfizer, Roche, and Tibotec. Arelly Ornelas and Isabel Bravo declare no competing interests. Roger Paredes has received consulting fees from Pfizer, Merck Sharp and Dohme, Roche Diagnostics. The IrsiCaixa AIDS Research Institute and the Lluita contra la SIDA Foundation have received grant support from Pfizer, ViiV Healthcare, Siemens, Merck Sharp and Dohme, and Boehringer Ingelheim for studies in which Dr. Paredes serves as principal investigator. This does not alter the authors‘ adherence to all the PLoS ONE policies on sharing data and materials.","2012","05","José R Santos","JRS",8,FALSE,NA,NA,1,5,TRUE,FALSE,FALSE,0,NA,FALSE
